Smartleaf Asset Management
COLL icon

Smartleaf Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Smartleaf Asset Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.76K Buy
304
+202
+198% +$5.9K ﹤0.01% 2603
2026
Q2 		$3.67K Hold
102
– – ﹤0.01% 2783
2026
Q1 		$3.26K Sell
102
-266
-72% -$11.3K ﹤0.01% 2812
2025
Q4 		$17.3K Hold
368
– – ﹤0.01% 2107
2025
Q3 		$12.7K Buy
368
+95
+35% +$3.3K ﹤0.01% 2008
2025
Q2 		$8.17K Sell
273
-82
-23% -$2.34K ﹤0.01% 1896
2025
Q1 		$10.5K Hold
355
– – ﹤0.01% 1906
2024
Q4 		$10.2K Buy
355
+283
+393% +$9.36K ﹤0.01% 1976
2024
Q3 		$2.75K Sell
72
-7
-9% -$250 ﹤0.01% 2371
2024
Q2 		$2.56K Buy
+79
New +$2.74K ﹤0.01% 2126

Other funds holding COLL

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Eventide Asset Management
Eventide Asset Management Boston, Massachusetts $7.14B AUM 65.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Smartleaf Asset Management's COLL Position: Q3 2026 in Review

Smartleaf Asset Management increased its Collegium Pharmaceutical (COLL) stake by 198% in Q3 2026, buying an estimated $5.9K and bringing the position to 304 shares worth $6.76K. The position accounts for ﹤0.01% of the portfolio, ranked #2603.

Smartleaf Asset Management first reported a position in COLL in Q2 2024 and has held it in 10 quarters since. The position peaked at $17.3K in Q4 2025. 185 funds tracked by Wall St. Rank hold COLL as of Q3 2026.

  • Smartleaf Asset Management held 304 shares of Collegium Pharmaceutical worth $6.76K as of Q3 2026.
  • Smartleaf Asset Management bought 202 Collegium Pharmaceutical shares in Q3 2026, an estimated $5.9K.
  • Collegium Pharmaceutical made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q3 2026, its #2603 holding.
  • Smartleaf Asset Management first reported a position in Collegium Pharmaceutical in Q2 2024 and has held it in 10 quarters since.
  • Smartleaf Asset Management's Collegium Pharmaceutical position peaked at $17.3K in Q4 2025.
  • 185 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2026.

Based on Smartleaf Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.